Össur key market sales normalize during second quarter
Prosthetics manufacturer Össur has experienced significant improvements to its growth in Q2 2021, compared to the same period last year which was hugely affected by covid-19.
BY RITZAU FINANS, TRANSLATED BY CATHERINE BRETT
Icelandic prosthetics firm Össur's key market sales have normalized during the second quarter of this year, with large growth achieved compared to the same period in 2020.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Össur advances in all areas after Covid-19-affected year
For subscribers
Ambu downgrades due to covid-19 and logistical challenges
For subscribers
.jpg&w=384&q=75)
